FluidAI Medical

What FluidAI Medical does

FluidAI Medical (legal entity NERv Technology Inc., founded 2014) is a Canadian medical device and AI company headquartered in Kitchener, Ontario, that builds data-driven solutions for postoperative care following gastrointestinal surgery. Its core platform combines a proprietary nanosensor-based hardware device, Origin, which attaches to standard surgical drains and continuously measures pH, electrical conductivity, and temperature of drainage fluid, with Stream Care, an AI-assisted Surgical Expert Suite that analyzes more than 100 clinical parameters from the device and from integrated EHR systems to predict postoperative complications such as anastomotic leaks, sepsis, bleeding, and respiratory failure. The company reports that its leak prediction model can identify clinically significant leaks by postoperative day 2 with 88.9% sensitivity and 75.3% specificity, and claims up to 89% accuracy across its postoperative complication models. FluidAI complements these products with Stream Inara, an AI-powered patient engagement platform (enhanced through the November 2025 acquisition of Emmetros Limited), Stream CMx for automated clinical documentation, and the RISE Program that packages the offerings around Enhanced Recovery After Surgery (ERAS) protocols.

The company is regulated in multiple jurisdictions: Origin received FDA 510(k) clearance in September 2025, alongside Health Canada and SFDA approvals, and FluidAI operates an ISO 13485- and MDSAP-certified manufacturing line in Kitchener. Its technology stack is anchored on a proprietary dataset of 350,000+ patient records and is supplemented through data partnerships, including access to Mayo Clinic Platform_Discover, and bidirectional integration with Epic and other EHR systems.

FluidAI sells to hospitals, academic medical centers, and health systems performing gastrointestinal and related surgeries, with named customers and partners including Cleveland Clinic, University Health Network, Hamilton Health Sciences, St. Michael's Hospital, Providence Health Care, Michigan Medicine, Grand River Hospital, King Saud University, and Medtronic Canada. Revenue is generated through hardware sales of Origin, software subscriptions for Stream Care and Stream Inara, and custom AI solution services; pricing is custom-quoted on annual enterprise contracts, with the company claiming per-patient savings of $43,000 per leak patient through early intervention and $5,000 per non-leak patient through confident early discharge. The company employs approximately 85 people, has raised a $15M Series A led by SOSV and Graphene Ventures, and received a $2M FedDev Ontario grant to scale manufacturing and commercialization.

Name

FluidAI Medical

Legal name

NERv Technology Inc.

Website

https://fluidai.md

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

51–100 employees

Short description

FluidAI Medical is a Canadian medical device and AI company that provides AI-driven postoperative monitoring for gastrointestinal surgery, selling its FDA-cleared Origin nanosensor device and Stream Care software platform to hospitals and health systems to enable early detection of surgical complications.

Ownership category

akta.pro rank

Product category

AI-driven postoperative monitoring medical devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Surgical, Perioperative & ERAS Pathway Tools (HLACAGAJ)

akta.pro secondary industries

Perioperative/Anesthesia & Surgical Documentation Systems (HLACAAAF), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Postoperative monitoring devices
• AI surgical analytics
• Anastomotic leak detection
• Continuous drain monitoring
• Medical device software

Headquarters

HQ city

Kitchener

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales (Origin™): Sale of FDA-cleared and Health Canada-approved monitoring device for postoperative care. Origin™ is sold as hardware with accompanying software integration.
2. Software Subscriptions (Stream Care™): AI-driven Surgical Expert Suite deployed as software subscription to hospitals for postoperative complication prediction and patient monitoring.
3. Patient Engagement Platform (Stream Inara™): AI-powered patient education and engagement platform acquired through Emmetros Limited, extending care beyond hospital to support earlier discharge.
4. Custom Solutions: Custom AI solutions development including Clinical Document Generation, Patient Engagement platforms, Custom AI Models, and Data Warehousing tailored to hospital needs.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

FluidAI Medical develops and sells AI-driven postoperative monitoring hardware and software for gastrointestinal and general surgery patients. Its flagship Origin™ device attaches to surgical drains to continuously measure pH, electrical conductivity, and temperature via proprietary nanosensors, while the Stream Care™ platform uses machine learning models on EHR and sensor data to predict postoperative complications such as anastomotic leaks up to six days before symptom onset. The portfolio also includes Stream Inara™ for patient engagement, Stream CMx™ for automated clinical documentation, and the RISE Program unifying the surgical journey from hospital to home recovery, sold primarily to hospitals and health systems through enterprise contracts.

Product overview

FluidAI Medical offers a unified platform-plus-modules architecture for data-driven surgical recovery. The core portfolio centers on Stream Care (AI-assisted Surgical Expert Suite) and Origin (FDA-cleared continuous monitoring device), which integrate to analyze EHR data and surgical drain fluid biochemistry for postoperative complication prediction. The platform extends through Stream Inara for patient engagement and Stream CMx for clinical documentation automation, all unified under the RISE (Recovery Intelligence and Surgical Excellence) Program. The system leverages proprietary ML models analyzing 100+ clinical parameters to predict complications up to 6 days before symptom onset, with demonstrated 88.9% sensitivity and 89% prediction accuracy. Custom Solutions services enable hospitals to develop tailored AI models and data infrastructure.

Differentiator

Problem solved

Functional benefit

Products and services

• Stream Care™ AI-assisted Surgical Expert Suite that consolidates and analyzes patient data from EHR systems and Origin sensors to predict postoperative complications including anastomotic leaks, sepsis, bleeding, and respiratory failure. Provides real-time risk prioritization and clinical decision support for gastrointestinal surgery patients in hospitals and health systems.
• Origin™ FDA-cleared real-time continuous monitoring device that attaches to surgical drains and measures pH, electrical conductivity, and temperature of drainage fluid via proprietary nanosensors. Designed to detect anastomotic leaks up to 6 days before symptom onset for gastrointestinal surgery patients in hospitals.
• Custom Solutions AI-powered custom solutions developed in partnership with hospital clinical teams to address specific surgical care challenges. Includes Custom AI Models for risk stratification, Data Warehousing for unified analytics, Clinical Document Generation, and Patient Engagement platforms tailored to institutional requirements.
• RISE Program Recovery Intelligence and Surgical Excellence Program unifying Stream Care™, FDA-cleared Origin™ monitoring device, and Stream Inara™ patient engagement platform to deliver data-driven surgical recovery and enable ERAS protocols across the entire surgical journey from hospital to home recovery for hospital and health system customers.

Quantifiable outcome

• Predicts complications up to 6 days before symptom onset (Day 2 prediction capability)
• +7 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature5 records

Partnerships

Twelve partnerships are on record, tiered core and supporting.

• Qaelon MedicalcoreStrategic or Co-development Partner · 1 May 2026Strategic collaboration to develop a unified surgical data ecosystem linking intraoperative leak detection (Qaelon's platform) with postoperative monitoring (FluidAI's FDA-cleared Origin device and Stream Care platform). Aims to create first integrated framework spanning full surgical journey from OR to recovery, targeting anastomotic leaks in gastrointestinal surgery.
• Emmetros LimitedcoreTechnology or Integration · 26 November 2025Acquisition of Emmetros Limited, developer of SparxConnect patient engagement platform. Enhances Stream Inara AI-powered patient education platform within FluidAI's RISE Program. Second acquisition after Medsix.
• Mayo Clinic PlatformcoreStrategic or Co-development Partner · 28 October 2024Collaboration to access de-identified clinical data through Mayo Clinic Platform_Discover. Enables FluidAI to accelerate development of predictive models using diverse datasets including demographics, diagnoses, imaging, lab results, clinical notes, and pathology reports for faster model development.
• DIGITAL (Canada's Global Innovation Cluster)coreStrategic or Co-development Partner · 9 September 2024Led the Postoperative Patient Management Platform (PPMP) project under DIGITAL, a $5.2M+ co-investment to revolutionize postoperative care through advanced AI and ML technologies. Partners include Medtronic, Excelar, Providence Health Care Ventures, and University of Waterloo.
• Excelar TechnologiessupportingTechnology or Integration · 9 September 2024Consortium partner in PPMP project, enhancing CareFlow platform to support broader AI-driven risk prediction use cases with data integration and visualization tools.
• Providence Health Care VenturessupportingImplementation/ SI/ Consulting Partner · 9 September 2024Consortium partner facilitating feasibility trials, validating solutions, and ensuring regulatory compliance. Provides portal to Providence Health Care in Vancouver for clinical validation.
• University of WaterloosupportingStrategic or Co-development Partner · 9 September 2024Consortium partner conducting user needs assessments to ensure platform meets healthcare providers' requirements. Academic research partner for technology development.
• Medtronic Canada ULCcoreStrategic or Co-development Partner · 14 September 2023Strategic partnership under DIGITAL's Continuous Connected Patient Care (CCPC) project to develop predictive analytics, AI, and home monitoring technology integrating with current medical systems for uninterrupted care from hospital to home.
• Simon Fraser UniversitysupportingStrategic or Co-development Partner · 14 September 2023Consortium partner in CCPC project, gathering user needs input to guide technology creation, clinical decision support framework, and user interfaces.
• Cloud DXsupportingTechnology or Integration · 14 September 2023Consortium partner providing secure, ISO-certified remote patient monitoring platform with patient engagement tools and clinician portal for the CCPC project.
• Bridge Health SolutionssupportingTechnology or Integration · 14 September 2023Consortium partner enhancing medication dispensing, tracking, and adherence monitoring solution within the CCPC project for home monitoring.
• StarFish MedicalsupportingTechnology or Integration · 14 September 2023Sub-contractor to Medtronic in CCPC project, contributing medical device development expertise.

Scale indicators13 records

Recent moves6 records

Expansion highlights7 records

Broad incumbents

• Medtronic: Global medical device leader with extensive GI surgery stapling portfolio and surgical monitoring capabilities. Direct strategic partner with FluidAI via Medtronic Canada and the CCPC project, while also representing the most significant competitive threat in surgical complication detection.
• Ethicon (Johnson & Johnson MedTech): Dominant provider of GI surgical stapling devices and anastomosis technology through its Ethicon franchise. The incumbent whose staplers and sealants are most directly involved in the surgeries where FluidAI's leak detection platform operates.
• Health Catalyst: Healthcare data and analytics platform serving hospitals with AI-driven insights from EHR and clinical data. Comparable in applying AI to integrated clinical data for risk prediction and quality improvement in health systems.
• Stryker: Major diversified medical device company with significant surgical equipment, endoscopy, and postoperative care offerings. Broad incumbent that competes for hospital surgical budgets and could expand into continuous postoperative monitoring.

Direct peers

• Caresyntax: AI-powered surgical intelligence platform combining OR data capture, analytics, and clinical decision support for hospitals. Most direct comparable to FluidAI's Stream Care platform in targeting surgical outcomes improvement through AI-driven insights.
• Qaelon Medical: Developer of an intraoperative leak detection platform for gastrointestinal surgery. Strategic partner with FluidAI as of May 2026 to link intraoperative and postoperative leak detection, addressing the same core clinical problem of anastomotic leaks.
• Surgical Safety Technologies: Provider of the OR Black Box platform that captures and analyzes operating room data for safety and quality improvement. Comparable in applying data analytics to surgical complications and outcomes measurement.
• Gauss Surgical: AI-driven blood loss monitoring platform using computer vision in the OR. Comparable as a real-time AI monitoring solution for surgical complications, with similar FDA-cleared medical device + AI software business model.

Emerging players

• Activ Surgical: Emerging AI surgical visualization and intelligence company building intraoperative AI to enhance surgeon decision-making. Comparable in applying AI to surgical workflows, though focused on intraoperative visualization rather than postoperative monitoring.
• Proximie: AI and AR-enabled surgical collaboration platform connecting surgeons for telesurgery and case support. Comparable as an emerging surgical AI platform targeting hospital digital transformation, with overlap in surgical workflow software.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/fluidaimedical
• Xx.com/FluidAIMedical

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries1 record

Funding overview

Funding rounds8 records

Investors29 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about FluidAI Medical